METHOD FOR ISSUING A BIOLOGICAL ENTITY

DE602021029089T2Active Publication Date: 2025-04-09CELL COPEDIA GMBH
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
DE602021029089
Authority / Receiving Office
DE · DE
Patent Type
Patents
Current Assignee / Owner
Priority Date
2020-01-31
Filing Date
2021-02-01
Publication Date
2025-04-09
Estimated Expiration
2041-02-01

AI Technical Summary

Technical Problem

Current cell separation techniques face limitations in yield, purity, viability, and functionality of isolated cells, particularly in recovering rare cells and improving throughput.

Method used

The method employs a chromatographic approach optimized with a dextran molecule as a carrier for ligand binding partners like Strep-Tactin, achieving an avidity effect through polymerization/multimerization, and using bivalent tagging agents or linking molecules to enhance cell isolation efficiency.

Benefits of technology

This approach results in high yields and purity of isolated cells, such as CD4+ cells, while maintaining cell viability and functionality, and is particularly effective for isolating cells with low abundant surface antigens.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader
Need to check novelty before this filing date? Find Prior Art
No text content released.